Market Place
Sourcing Support
PDS Bio Reveals $11.1M Direct Offering
11 Nov 2025 //
GLOBENEWSWIRE
PDS VERSATILE-002 Trial Meets Endpoints In HPV16+ Head/Neck Cancer
09 May 2024 //
GLOBENEWSWIRE
PDS Bio Announces Study Results in HPV-Positive Head and Neck Cancer Patients
23 Oct 2023 //
GLOBENEWSWIRE
PDS Bio Announces Submission of Phase 3 Protocol to Initiate VERSATILE-003 Trial
14 Aug 2023 //
GLOBENEWSWIRE
PDS Biotechnology Announces Webcast for Second Quarter 2023 Financial Results
07 Aug 2023 //
GLOBENEWSWIRE
PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023
02 Aug 2023 //
GLOBENEWSWIRE
PDS Announces Achievement of Efficacy in Stage 2 of the VERSATILE-002 Trial
14 Jun 2023 //
GLOBENEWSWIRE
PDS Biotechnology Post-ASCO Conference Call Tomorrow, June 6, at 8 a.m. ET
05 Jun 2023 //
GLOBENEWSWIRE
PDS Announces Conference and Webcast for Fourth Quarter 2022 Financial Results
16 Mar 2023 //
GLOBENEWSWIRE
PDS Announces Publication Showing Superior CD4 T Cell Induction by Infectimune
16 Feb 2023 //
GLOBENEWSWIRE
Merck KGaA hands over IL-12 cancer med for up to $121M
04 Jan 2023 //
FIERCE BIOTECH
PDS Completes First Stage of Enrollment of PII Trial in HPV16 Positive Head
15 Dec 2022 //
GLOBENEWSWIRE
PDS Biotech Executives to Present an Overview of Oncology
21 Nov 2022 //
GLOBENEWSWIRE
PDS Biotech Announces 100% Clinical Response in Cervical Cancer Patients
14 Nov 2022 //
GLOBENEWSWIRE
PDS Biotech Reports Third Quarter 2022 Financial Results
14 Nov 2022 //
GLOBENEWSWIRE
PDS Biotech Announces Presentation of Preliminary PDS0101 Efficacy
07 Nov 2022 //
PRESS RELEASE
PDS Biotechnology Announces Conference Call for Q3 2022 Financial Results
31 Oct 2022 //
GLOBENEWSWIRE
PDS Biotech Provides Highlights from Head and Neck Cancer KOL Roundtable
27 Oct 2022 //
GLOBENEWSWIRE
PDS Biotech CMO Dr. Lauren V. Wood to Address 2022 Conference
25 Oct 2022 //
GLOBENEWSWIRE
PDS Biotech to Present at the LD Micro Main Event XV
19 Oct 2022 //
GLOBENEWSWIRE
PDS Biotech Announces Abstract Demonstrating Versatility of the Versamune®
17 Oct 2022 //
GLOBENEWSWIRE
PDS Biotech Announces Expanded Interim Data in PDS0101 Triple Combo Ph2 Trial
11 Oct 2022 //
GLOBENEWSWIRE
PDS Biotech Reports An Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
07 Oct 2022 //
GLOBENEWSWIRE
PDS Biotech Announces Abstracts Involving Research of PDS0101 Accepted
05 Oct 2022 //
GLOBENEWSWIRE
PDS Biotech Announces Successful End-of-Phase 2 Meeting With the FDA
03 Oct 2022 //
GLOBENEWSWIRE
PDS Biotech Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
23 Sep 2022 //
GLOBENEWSWIRE
PDS Biotech & National Cancer Institute Identify Optimal Patient Group PDS0101
21 Sep 2022 //
GLOBENEWSWIRE
PDS Biotech to Participate at H.C. Wainwright 24th AnnualGIC
06 Sep 2022 //
GLOBENEWSWIRE
PDS Biotech Completes $35 Million Financing Agreement Led By Horizon Technology
24 Aug 2022 //
GLOBENEWSWIRE
PDS Biotech Reports Second Quarter 2022 Financial Results
08 Aug 2022 //
GLOBENEWSWIRE
PDS Biotech Independent Data Monitoring Committee Recommends VERSATILE-002 Trial
04 Aug 2022 //
GLOBENEWSWIRE
PDS Biotech to Participate at BTIG Biotechnology Conference 2022
02 Aug 2022 //
GLOBENEWSWIRE
PDS Biotechnology Announces Conference Call for Q2 2022 Financial Results
26 Jul 2022 //
GLOBENEWSWIRE
PDS Bio Announces Presentation of Universal Flu Vaccine Preclinical Data
14 Jul 2022 //
GLOBENEWSWIRE
PDS Biotech Appoints Spencer Brown as Senior Vice President, General Counsel
03 Jun 2022 //
GLOBENEWSWIRE
PDS Biotechnology Granted FDA Fast Track Designation for Lead Candidate PDS0101
02 Jun 2022 //
GLOBENEWSWIRE
PDS Biotech Announces Expansion of its VERSATILE-002 Clinical Trial into Europe
31 May 2022 //
GLOBENEWSWIRE
PDS Biotech to Present Efficacy and Safety Data from VERSATILE-002 PII Trial
26 May 2022 //
GLOBENEWSWIRE
PDS Biotech to Present Data from NCI-Led Triple Combination PII Trial
26 May 2022 //
GLOBENEWSWIRE
PDS Biotech to Participate at Upcoming Investor Conferences
17 May 2022 //
GLOBENEWSWIRE
PDS Biotech Reports First Quarter 2022 Financial Results
11 May 2022 //
GLOBENEWSWIRE
PDS Biotechnology Announces Conference Call for Q1 2022 Financial Results
28 Apr 2022 //
GLOBENEWSWIRE
PDS Biotech Announces Two Abstracts Accepted for Presentation at the 2022 ASCO
27 Apr 2022 //
GLOBENEWSWIRE
PDS Biotech CMO, Lauren V. Wood, to Chair Session at the World Vaccine Congress
20 Apr 2022 //
GLOBENEWSWIRE
PDS Biotech Receives $1.2M After Selling Its Net Operating Loss Tax Benefits
19 Apr 2022 //
GLOBENEWSWIRE
PDS Biotechnology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08 Apr 2022 //
GLOBENEWSWIRE
PDS Biotech Reports Fourth-Quarter and Full-Year 2021 Financial Results
31 Mar 2022 //
GLOBENEWSWIRE
PDS Bio Reschedules 2021 Q4 and Full Year Financial Results and Conference Call
22 Mar 2022 //
GLOBENEWSWIRE
Quipt Home Medical to Participate at Sidoti Virtual Investor Conference
15 Mar 2022 //
GLOBENEWSWIRE
PDS Bio to Announce Q4 and FY 2021 Financial Results
09 Mar 2022 //
GLOBENEWSWIRE
PDS Bio to Present at the 32nd Oppenheimer Annual Healthcare Conference
01 Mar 2022 //
GLOBENEWSWIRE
PDS Biotech Announces Preliminary Safety Data on PDS0101+KEYTRUDA
24 Feb 2022 //
GLOBENEWSWIRE
PDS Biotech Announces Preclinical Data for PDS0202 Universal Influenza Vaccine
27 Jan 2022 //
GLOBENEWSWIRE
PDS Biotech Announces Presentation of PDS0101 Data
12 Jan 2022 //
GLOBENEWSWIRE
PDS Biotech Granted Patent for its Novel HPV16 Immunotherapy
10 Jan 2022 //
GLOBENEWSWIRE
PDS Biotech Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
23 Dec 2021 //
GLOBENEWSWIRE
PDS Biotech Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
23 Dec 2021 //
GLOBENEWSWIRE
PDS Biotechnology Licenses Protein for the Treatment of Acute Myeloid Leukemia
08 Nov 2021 //
GLOBENEWSWIRE
PDS Biotech Announces Agreement with University of Georgia to License
01 Nov 2021 //
GLOBENEWSWIRE
PDS Biotech Chief Medical Officer, Lauren V. Wood, to Present at the 2021
27 Oct 2021 //
GLOBENEWSWIRE
